As of late, it has been hard for us to write about anything other than COVID-19. The pandemic is unprecedented, and for any healthcare-related organization the virus has had an impact. TREND is no exception. But we specialize in rare and underserved diseases, and even though the world is united in its quest for a COVID vaccine, we can’t forget the daily battle so many rare disease patients are facing along with the lack of attention their illnesses receive. This is especially true for ultra-rare
In the wake of the COVID-19 crisis, different entities around the world are trying to minimize the amount of time it takes to get critical information. One promising endeavor is the COVID-19 Evidence Accelerator.